Fetanat Sadaf, ShahAli Shabnam, Dadgoo Mehdi, Noorizadeh Dehkordi Shohreh, Naghian Fesharaki Mehdi
Iranian Center of Excellence in Physiotherapy, Rehabilitation Research Center, Department of Physiotherapy, School of Rehabilitation Sciences, Iran University of Medical Sciences, Tehran, Iran.
Iranian Center of Excellence in Physiotherapy, Rehabilitation Research Center, Department of Physiotherapy, School of Rehabilitation Sciences, Iran University of Medical Sciences, Tehran, Iran
BMJ Open. 2025 Mar 3;15(3):e093691. doi: 10.1136/bmjopen-2024-093691.
Postpartum lumbopelvic pain (LPP) is a prevalent condition among women following childbirth. Due to the importance of respiratory muscles in lumbopelvic stability, and the changes they undergo during pregnancy, this study aims to assess the effects of motor control training and breathing exercises on pain, disability and core muscle activity in women suffering from LPP after childbirth.
52 women with postpartum LPP will participate in this two-parallel-armed, superiority randomised controlled trial, comprising 24 treatment sessions. The intervention group consists of motor control training and breathing exercises, and the control group includes motor control training. The diaphragm excursion, pelvic floor and abdominal muscle activity, pain and disability will be evaluated using ultrasound imaging, visual analogue scale and Oswestry Disability Index, before and after the intervention, respectively.
Ethical approval was obtained from the human research ethics committee of the Iran University of Medical Sciences (IR.IUMS.REC.1403.017). The study results will be submitted to a relevant journal and conferences.
This clinical trial has been registered in the Iranian Registry of Clinical Trials on 21 May 2024 (registration number: IRCT20180916041051N2).
产后腰骨盆疼痛(LPP)是女性产后的一种常见病症。鉴于呼吸肌在腰骨盆稳定性中的重要性以及它们在孕期所经历的变化,本研究旨在评估运动控制训练和呼吸练习对产后患有LPP的女性的疼痛、功能障碍和核心肌肉活动的影响。
52名产后LPP女性将参与这项两平行组、优效性随机对照试验,共包括24个治疗疗程。干预组包括运动控制训练和呼吸练习,对照组包括运动控制训练。分别在干预前后,使用超声成像、视觉模拟量表和Oswestry功能障碍指数评估膈肌活动度、盆底和腹部肌肉活动、疼痛及功能障碍。
已获得伊朗医科大学人类研究伦理委员会的伦理批准(IR.IUMS.REC.1403.017)。研究结果将提交给相关期刊和会议。
本临床试验已于2024年5月21日在伊朗临床试验注册中心注册(注册号:IRCT20180916041051N2)。